The Investor Relations website contains information about BioCryst Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial ...
People also ask
Is BCRX stock a good buy?
Why is BCRX dropping?
Who owns BCRX?
Is BioCryst a good company to work for?
We are BioCryst, a different kind of biotech company. Learn about our commitment to the rare disease patient community and discover career opportunities.
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Feb 28, 2024 · BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript February 26, 2024 ... (NASDAQ:BCRX) ... Investor Relations website at ...
Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the Earnings Calendar to see dates for ...
(US:BCRX) has 431 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions ...
Inv Rel Email Address, investorrelations@biocryst.com ; General Email Address, info@biocryst.com ; Email Contact Form on Website, Goto Email Form ...
